Sharing Decisions in Cancer Care Important but Difficult to Implement
the Cancer Therapy Advisor take:
Medical specialists recognized the importance of sharing the decision-making process with patients but found it to be difficult to implement in practice, according to an article published online in the journal The Oncologist.
In this study, medical specialists were interviewed and a focus group was established. In the focus group, the investigators analyzed the specialists’ opinions regarding shared decision-making, patient involvement, and their applicability in the context of patients with glioblastoma.
Results showed health care professionals considered patient involvement in decision-making to be important; however, most did not follow through with its elements. Furthermore, specialists did not consider stopping treatment to be equal to continuing treatment.
The authors identified preferences of both patients and medical specialists for starting or continuing treatment and specialists’ assumptions of knowing the patients’ desires as being the major barriers to shared decision-making.
The study suggests training be made available for physicians in order to improve communication and patient involvement in the decision-making process, especially for patients with glioblastoma.
Medical specialists recognized the importance of sharing the decision-making process with patients but found it to be difficult to implement in practice.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Complete Resection of Metastatic Soft Tissue Sarcoma Associated With Improved Disease-specific Survival
- The Challenges of Immunotherapy Re-challenge in Metastatic Melanoma
- FDA Approves Fulvestrant/Abemaciclib Combination for Breast Cancer
- Beta-blockers May Prevent Stress-induced Lung Cancer Treatment Resistance
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- FDA Expands Sunitinib Indication To Include Adjuvant Therapy for Renal Cell Carcinoma
- Ultrasonography May Detect Thyroid Cancer Growth Arrest, Negating Need for Treatment
- Does Education Level Predict PSA Screening and Prostate Cancer Survival?
- Unrelated HSCT, UCBT May Yield Similar Survival Outcomes in Acute Leukemia
- Minimal Residual Disease and Patient Genotype May Inform Relapse Risk Algorithms in ALL